Correction: Establishing standardized immune phenotyping of metastatic melanoma by digital pathology.

Saved in:
Bibliographic Details
Title: Correction: Establishing standardized immune phenotyping of metastatic melanoma by digital pathology.
Authors: Sobottka B; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. annabettina.sobottka-brillout@usz.ch., Nowak M; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Frei AL; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Haberecker M; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Merki S; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Levesque MP; Department of Dermatology, University and University Hospital Zurich, Zurich, Switzerland., Dummer R; Department of Dermatology, University and University Hospital Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland., Koelzer VH; Department of Pathology and Molecular Pathology, University and University Hospital Zurich, Zurich, Switzerland. viktor.koelzer@usz.ch.
Corporate Authors: Tumor Profiler Consortium
Source: Laboratory investigation; a journal of technical methods and pathology [Lab Invest] 2021 Dec; Vol. 101 (12), pp. 1637.
Publication Type: Published Erratum
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0376617 Publication Model: Print Cited Medium: Internet ISSN: 1530-0307 (Electronic) Linking ISSN: 00236837 NLM ISO Abbreviation: Lab Invest Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0307
DOI:10.1038/s41374-021-00676-5